Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Schrodinger Inc
(NQ:
SDGR
)
20.67
-0.18 (-0.86%)
Streaming Delayed Price
Updated: 1:44 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
148,658
Open
20.69
Bid (Size)
20.67 (3)
Ask (Size)
20.70 (1)
Prev. Close
20.85
Today's Range
20.36 - 20.80
52wk Range
18.02 - 38.00
Shares Outstanding
62,027,061
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week
Today 4:54 EDT
The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030.
Via
Talk Markets
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 16, 2024
From
Schrödinger
Via
Business Wire
Performance
YTD
-41.16%
-41.16%
1 Month
-7.10%
-7.10%
3 Month
-6.51%
-6.51%
6 Month
-34.34%
-34.34%
1 Year
-42.29%
-42.29%
More News
Read More
AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD
August 14, 2024
Via
Talk Markets
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
August 14, 2024
From
Schrödinger
Via
Business Wire
What Analysts Are Saying About Schrodinger Stock
July 11, 2024
Via
Benzinga
The 3 Best Med Tech Stocks to Buy Now
August 05, 2024
Via
InvestorPlace
SDGR Stock Earnings: Schrodinger Beats EPS, Beats Revenue for Q2 2024
July 31, 2024
Via
InvestorPlace
Schrödinger Reports Strong Second Quarter 2024 Financial Results
July 31, 2024
From
Schrödinger
Via
Business Wire
AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD
July 30, 2024
Via
Talk Markets
3 Small-Cap Stocks to Buy at a 52-Week Low
July 27, 2024
Via
InvestorPlace
Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology
July 26, 2024
From
Schrödinger
Via
Business Wire
3 Stocks That Could Benefit Big Time From Coming Interest Rate Cuts
July 22, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD
July 18, 2024
Via
Talk Markets
Schrödinger to Announce Second Quarter 2024 Financial Results on July 31
July 17, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 16, 2024
From
Schrödinger
Via
Business Wire
Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
July 14, 2024
Via
Talk Markets
Simulations Plus Stock Drops 15% Despite EPS Beat
July 05, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Top-Rated Gene Editing Stocks Actually Making Money
July 03, 2024
Via
InvestorPlace
Largest Clinical-Stage BioTech Drug Stocks Declined 6%
June 22, 2024
Via
Talk Markets
AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th
June 17, 2024
Via
Talk Markets
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 14, 2024
From
Schrödinger
Via
Business Wire
AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week
June 10, 2024
Via
Talk Markets
The 7 AI Categories Were Down 4%, On Average, This Week; Up 1% In May
June 01, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Schrödinger to Present at Jefferies Global Healthcare Conference
May 22, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024
From
Schrödinger
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.